Breast Cancer Trial, Recruiting NCT03824145 Sponsor: Medical College of Wisconsin Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT03824145
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female and aged 18 or older
  • People who have been diagnosed with metastatic breast cancer (breast cancer that has spread to other parts of the body)
  • People who have brain metastases (cancer that has spread to the brain) that have been treated and are currently stable
  • People whose oncologist has provided written permission for them to take part in the study
  • People who have been assessed by their medical oncologist as "clinically stable," meaning: no unintentional weight loss, no new symptoms or changes in physical functioning in the past 4 weeks, no signs in tests or scans of the cancer getting worse, no recent or planned changes to cancer treatment, and no severe pain
  • People who are expected to live for more than 6 months
  • People who have access to a mobile phone
  • People who speak and understand English fluently
  • People who are not currently meeting the American Cancer Society's recommended guidelines for nutrition or physical activity for cancer survivors, as shown through a questionnaire

Who may not be able to join:

  • People who do not meet all of the above criteria

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Melinda Stolley, PhD, Principal Investigator

Phone: 414-955-2114

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical College of Wisconsin
Registry
ClinicalTrials.gov
Start date
1 November 2022
Est. completion
1 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Intervention adherence; Intervention retention; Intervention retention; Change in Quality of Life; Change in Quality of Life; Body composition; Body composition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov